Mesenflow Technologies

Proprietary human organoid technology for inflammatory response measurement

placeGeneva, Geneva, Switzerland calendar_todayFounded 2016 language mesenflow.com

Social engagement

Social engagement: 256 social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Accelerator & incubator3100%

Recent activity

29 May 2026
Partnership
HEPIA
9 Apr 2026
Product launch
MesenCount
Coming soon